Prashant Kohli - Dec 19, 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
Chief Executive Officer, Director
Signature
/s/ Prashant Kohli
Stock symbol
ACST
Transactions as of
Dec 19, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 04:05 PM
Previous filing
Jul 18, 2023
Next filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +41.7K $0.00 41.7K Dec 19, 2023 Class A Common Shares 41.7K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which fully vested upon grant.